206 related articles for article (PubMed ID: 33197752)
1. The head and neck cancer genome in the era of immunotherapy.
Wijetunga NA; Yu Y; Morris LG; Lee N; Riaz N
Oral Oncol; 2021 Jan; 112():105040. PubMed ID: 33197752
[TBL] [Abstract][Full Text] [Related]
2. The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments.
Outh-Gauer S; Morini A; Tartour E; Lépine C; Jung AC; Badoual C
Head Neck Pathol; 2020 Jun; 14(2):330-340. PubMed ID: 32124416
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
[TBL] [Abstract][Full Text] [Related]
5. Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma.
Seliger B; Massa C; Yang B; Bethmann D; Kappler M; Eckert AW; Wickenhauser C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987799
[TBL] [Abstract][Full Text] [Related]
6. APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
Faden DL; Ding F; Lin Y; Zhai S; Kuo F; Chan TA; Morris LG; Ferris RL
Oral Oncol; 2019 Sep; 96():140-147. PubMed ID: 31422205
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
8. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
[TBL] [Abstract][Full Text] [Related]
9. HPV and the Immune System in Head and Neck Cancers: Therapeutic Considerations.
Grinnell M; Krishnan M; Ganti AK
Oncology (Williston Park); 2020 Apr; 34(4):. PubMed ID: 32293695
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC.
Gong X; Xiong J; Gong Y; Zhang J; Zhang J; Yang G; Chi H; Tian G
Front Immunol; 2023; 14():1275270. PubMed ID: 37876923
[TBL] [Abstract][Full Text] [Related]
11. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
[TBL] [Abstract][Full Text] [Related]
12. The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer.
Wang HF; Wang SS; Tang YJ; Chen Y; Zheng M; Tang YL; Liang XH
Front Immunol; 2019; 10():653. PubMed ID: 31001266
[TBL] [Abstract][Full Text] [Related]
13. HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
Zeng H; Song X; Ji J; Chen L; Liao Q; Ma X
BMC Cancer; 2020 Aug; 20(1):796. PubMed ID: 32831060
[TBL] [Abstract][Full Text] [Related]
14. The molecular landscape of head and neck cancer.
Leemans CR; Snijders PJF; Brakenhoff RH
Nat Rev Cancer; 2018 May; 18(5):269-282. PubMed ID: 29497144
[TBL] [Abstract][Full Text] [Related]
15. HNSCC: Tumour Antigens and Their Targeting by Immunotherapy.
von Witzleben A; Wang C; Laban S; Savelyeva N; Ottensmeier CH
Cells; 2020 Sep; 9(9):. PubMed ID: 32942747
[TBL] [Abstract][Full Text] [Related]
16. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.
Faraji F; Zaidi M; Fakhry C; Gaykalova DA
Microbes Infect; 2017; 19(9-10):464-475. PubMed ID: 28619685
[TBL] [Abstract][Full Text] [Related]
18. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.
Ruffin AT; Li H; Vujanovic L; Zandberg DP; Ferris RL; Bruno TC
Nat Rev Cancer; 2023 Mar; 23(3):173-188. PubMed ID: 36456755
[TBL] [Abstract][Full Text] [Related]
19. The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
Chen S; Lai H; Zhao J; Chen B; Li Y; Li Y; Li Q; Zheng Q; Huang S; Zhu X
BMC Cancer; 2021 Nov; 21(1):1183. PubMed ID: 34740324
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Head and Neck Cancer.
Sim F; Leidner R; Bell RB
Hematol Oncol Clin North Am; 2019 Apr; 33(2):301-321. PubMed ID: 30833002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
